Cargando…

Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening

BACKGROUND: Prediction of patient survival from tumor molecular ‘-omics’ data is a key step toward personalized medicine. Cox models performed on RNA profiling datasets are popular for clinical outcome predictions. But these models are applied in the context of “high dimension”, as the number p of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardillier, Rémy, Koca, Dzenis, Chatelain, Florent, Guyon, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533541/
https://www.ncbi.nlm.nih.gov/pubmed/36199072
http://dx.doi.org/10.1186/s12885-022-10117-1
_version_ 1784802368801472512
author Jardillier, Rémy
Koca, Dzenis
Chatelain, Florent
Guyon, Laurent
author_facet Jardillier, Rémy
Koca, Dzenis
Chatelain, Florent
Guyon, Laurent
author_sort Jardillier, Rémy
collection PubMed
description BACKGROUND: Prediction of patient survival from tumor molecular ‘-omics’ data is a key step toward personalized medicine. Cox models performed on RNA profiling datasets are popular for clinical outcome predictions. But these models are applied in the context of “high dimension”, as the number p of covariates (gene expressions) greatly exceeds the number n of patients and e of events. Thus, pre-screening together with penalization methods are widely used for dimensional reduction. METHODS: In the present paper, (i) we benchmark the performance of the lasso penalization and three variants (i.e., ridge, elastic net, adaptive elastic net) on 16 cancers from TCGA after pre-screening, (ii) we propose a bi-dimensional pre-screening procedure based on both gene variability and p-values from single variable Cox models to predict survival, and (iii) we compare our results with iterative sure independence screening (ISIS). RESULTS: First, we show that integration of mRNA-seq data with clinical data improves predictions over clinical data alone. Second, our bi-dimensional pre-screening procedure can only improve, in moderation, the C-index and/or the integrated Brier score, while excluding irrelevant genes for prediction. We demonstrate that the different penalization methods reached comparable prediction performances, with slight differences among datasets. Finally, we provide advice in the case of multi-omics data integration. CONCLUSIONS: Tumor profiles convey more prognostic information than clinical variables such as stage for many cancer subtypes. Lasso and Ridge penalizations perform similarly than Elastic Net penalizations for Cox models in high-dimension. Pre-screening of the top 200 genes in term of single variable Cox model p-values is a practical way to reduce dimension, which may be particularly useful when integrating multi-omics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10117-1.
format Online
Article
Text
id pubmed-9533541
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95335412022-10-06 Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening Jardillier, Rémy Koca, Dzenis Chatelain, Florent Guyon, Laurent BMC Cancer Research BACKGROUND: Prediction of patient survival from tumor molecular ‘-omics’ data is a key step toward personalized medicine. Cox models performed on RNA profiling datasets are popular for clinical outcome predictions. But these models are applied in the context of “high dimension”, as the number p of covariates (gene expressions) greatly exceeds the number n of patients and e of events. Thus, pre-screening together with penalization methods are widely used for dimensional reduction. METHODS: In the present paper, (i) we benchmark the performance of the lasso penalization and three variants (i.e., ridge, elastic net, adaptive elastic net) on 16 cancers from TCGA after pre-screening, (ii) we propose a bi-dimensional pre-screening procedure based on both gene variability and p-values from single variable Cox models to predict survival, and (iii) we compare our results with iterative sure independence screening (ISIS). RESULTS: First, we show that integration of mRNA-seq data with clinical data improves predictions over clinical data alone. Second, our bi-dimensional pre-screening procedure can only improve, in moderation, the C-index and/or the integrated Brier score, while excluding irrelevant genes for prediction. We demonstrate that the different penalization methods reached comparable prediction performances, with slight differences among datasets. Finally, we provide advice in the case of multi-omics data integration. CONCLUSIONS: Tumor profiles convey more prognostic information than clinical variables such as stage for many cancer subtypes. Lasso and Ridge penalizations perform similarly than Elastic Net penalizations for Cox models in high-dimension. Pre-screening of the top 200 genes in term of single variable Cox model p-values is a practical way to reduce dimension, which may be particularly useful when integrating multi-omics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10117-1. BioMed Central 2022-10-05 /pmc/articles/PMC9533541/ /pubmed/36199072 http://dx.doi.org/10.1186/s12885-022-10117-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jardillier, Rémy
Koca, Dzenis
Chatelain, Florent
Guyon, Laurent
Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
title Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
title_full Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
title_fullStr Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
title_full_unstemmed Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
title_short Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
title_sort prognosis of lasso-like penalized cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533541/
https://www.ncbi.nlm.nih.gov/pubmed/36199072
http://dx.doi.org/10.1186/s12885-022-10117-1
work_keys_str_mv AT jardillierremy prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening
AT kocadzenis prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening
AT chatelainflorent prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening
AT guyonlaurent prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening